InjecTec

Botox Syringe Cradle for Precision Dosage Injections

Non Active, Mar 2017
Mature Ness Ziona, Israel Founded 2011
LinkedIn
Last updated 2026-06-18
Total raised
Stage
Mature
Founded
2011
Headcount
1
HQ
Ness Ziona, Israel
Sector

About

InjecTec has developed MultiTox, an innovative cradle for multi-use injections. The MultiTox cradle and syringe address the need for accuracy, precise placement, and exact dosage during botulinum toxin injections. The cradle accepts a standard sterile syringe and moves the plunger in a stepped manner to facilitate precise, multiple dosages of botulinum toxin. The patent-pending MultiTox cradle is positioned in the hand the same way a syringe is held. Pressing with the palm or the thumb activates the syringe. InjecTec is part of the BDR Group.

Q&A

What is InjecTec's primary product?
InjecTec has developed MultiTox, an innovative cradle for multi-use injections designed to provide accuracy, precise placement, and exact dosage during botulinum toxin injections.
When was InjecTec founded?
InjecTec was founded in January 2011.
What is the current status of InjecTec?
InjecTec is currently inactive, a status it reached in March 2017.
Where is InjecTec headquartered?
InjecTec is headquartered in Ness Ziona, Center District, Israel.
Who is the founder and CEO of InjecTec?
Gershon Goldenberg is the Founder and CEO of InjecTec.
What industry sectors does InjecTec operate in?
InjecTec operates in the Health Tech & Life Sciences, Medical Devices, and Aesthetic Devices sectors.
What is InjecTec's relationship with the BDR Group?
InjecTec is part of the BDR Group.

Team · 1

Founder · Founder & CEO
LinkedIn ↗

Sectors & technology

Sub-sectors
Health Tech & Life SciencesMedical DevicesAesthetic Devices
Target customers
Healthcare & Life SciencesHealthcareProvidersLife SciencesCosmetics
Business model
B2B

Highlights

Verified

Tags

doctorsmedical-devicescosmeticspatent-pendingmedical-equipmentclinics
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)